University of Florida
Lucas moved to the University of Florida in 2006 from the Robarts Research Institute and University of Western Ontario in London, Ontario, Canada, where she has been a principal investigator studying inflammation, specifically monocyte and T lymphocyte activation in vascular disease. Dr. Lucas is also co-inventor and co-founding scientist for Viron Therapeutics Inc., a biotechnology company that is now in clinical trial analyzing viral anti-inflammatory proteins as a new class of therapeutic agents. Dr. Lucas is a practicing interventional cardiologist in addition to running an active basic research lab in vascular inflammatory research with bovver 100 paper and reviews and 16 patents published. She has been an active member of the Canadian Society for Atherosclerosis and Thrombosis Board having also served as Editor-in-Chief and serves on the American Heart Association grant panel. She is additionally on the editorial board for several journals. Dr. Lucas also directs an annual medical mission to Fte. Liberté in Haiti.
Ion channels, functional genomics and proteomics, phenomics, cardiac electrophysiology and pharmacology, cardiac ischemia, cardioprotection, myocardial hypertrophy and heart failure.